• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Pulmonol . Observational Study: Lung Function and Symptom Control in Youth With Asthma up to 34 Months After COVID-19

tetano

Editor, Senior Moderator
Pediatr Pulmonol


. 2025 Sep;60(9):e71288.
doi: 10.1002/ppul.71288. Observational Study: Lung Function and Symptom Control in Youth With Asthma up to 34 Months After COVID-19

Kristina Gaietto[SUP] 1 [/SUP], Nicholas Bergum[SUP] 2 [/SUP], Daniel J Weiner[SUP] 1 [/SUP], Erick Forno[SUP] 3 [/SUP]



Affiliations
Abstract

Introduction: Prior studies of pediatric asthma control and lung function after COVID-19 have been limited by short follow-up intervals. We aimed to evaluate symptom control and lung function in children with asthma up to 34 months post-COVID-19.
Methods: We conducted a prospective observational chart review study. We reviewed electronic health records of children with asthma in the Western Pennsylvania COVID-19 Registry, abstracting pre- and all post-infection spirometry results and Childhood Asthma Control Test (C-ACT) or Asthma Control Test (ACT) scores (to measure symptom control) through August 2023. We conducted adjusted mixed models with linear spline to compare C-ACT/ACT or FEV[SUB]1[/SUB] before and after COVID-19. For individuals with worse outcomes at initial follow-up, we evaluated characteristics associated with lack of eventual recovery.
Results: We found no significant differences between baseline and post-infection symptom control (n = 267) or lung function (n = 196). Of the 28% of children who had worse lung function at initial follow-up, 34% fully recovered at final follow-up. Of the 19% with worse C-ACT/ACT score at initial follow-up, 38% fully recovered at final follow-up. Final follow-up median C-ACT/ACT scores and mean FEV[SUB]1[/SUB] were in the normal range even for the group without eventual recovery. Obesity (p = 0.04) was associated with hindered symptom control recovery.
Conclusion: There were no significant differences between baseline and follow-up symptom control or lung function in children with asthma up to 34 months post-COVID-19. Only a small proportion of children worsened and did not recover, and decrements were generally small. Obesity was associated with impaired symptom control recovery.

Keywords: SARS‐CoV‐2; child; pediatrics.

 
Back
Top